These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11463920)

  • 21. Performance of two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies.
    Reddy SM; Balakrishnan P; Uma S; Thyagarajan SP; Solomon S
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):359-60. PubMed ID: 15699434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus.
    Martins TB; Woolstenhulme RD; Jaskowski TD; Hill HR; Litwin CM
    Am J Clin Pathol; 2001 Feb; 115(2):272-7. PubMed ID: 11211617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
    Morrow RA; Friedrich D; Meier A; Corey L
    BMC Infect Dis; 2005 Oct; 5():84. PubMed ID: 16225691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serologic herpes testing in the real world: validation of new type-specific serologic herpes simplex virus tests in a public health laboratory.
    Turner KR; Wong EH; Kent CK; Klausner JD
    Sex Transm Dis; 2002 Jul; 29(7):422-5. PubMed ID: 12170133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genital herpes. Type-specific antibodies for diagnosis and management.
    Ashley RL
    Dermatol Clin; 1998 Oct; 16(4):789-93, xiii-xiv. PubMed ID: 9891682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a near-patient test and 2 enzyme-linked immunosorbent assay-based assays for detecting anti-herpes simplex virus type-2 antibodies.
    Palù G; Calistri A; Cancellotti E; Cusan M; Mengoli C;
    Scand J Infect Dis; 2001; 33(10):794-6. PubMed ID: 11728057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays.
    Liermann K; Schäfler A; Henke A; Sauerbrei A
    J Virol Methods; 2014 Apr; 199():29-34. PubMed ID: 24418499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common use of inaccurate antibody assays to identify infection status with herpes simplex virus type 2.
    Morrow RA; Brown ZA
    Am J Obstet Gynecol; 2005 Aug; 193(2):361-2. PubMed ID: 16098855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
    Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
    Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated microneutralization: method and comparison with western blot for type-specific detection of herpes simplex antibodies in two pregnant populations.
    Garland SM; Lee TN; Ashley RL; Corey L; Sacks SL
    J Virol Methods; 1995 Nov; 55(3):285-94. PubMed ID: 8609194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy.
    Arvaja M; Lehtinen M; Koskela P; Lappalainen M; Paavonen J; Vesikari T
    Sex Transm Infect; 1999 Jun; 75(3):168-71. PubMed ID: 10448394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and differentiation of herpes simplex virus types 1 and 2 by a duplex LightCycler PCR that incorporates an internal control PCR reaction.
    Whiley DM; Mackay IM; Syrmis MW; Witt MJ; Sloots TP
    J Clin Virol; 2004 May; 30(1):32-8. PubMed ID: 15072751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
    Wald A; Ashley-Morrow R
    Clin Infect Dis; 2002 Oct; 35(Suppl 2):S173-82. PubMed ID: 12353203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
    Jonsson MK; Levi M; Rudén U; Wahren B
    Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type-specific testing for herpes simplex virus.
    Strick L; Wald A
    Expert Rev Mol Diagn; 2004 Jul; 4(4):443-53. PubMed ID: 15225092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The reliability of serological tests for the diagnosis of genital herpes: a critique.
    Field PR; Ho DW; Irving WL; Isaacs D; Cunningham AL
    Pathology; 1993 Apr; 25(2):175-9. PubMed ID: 8396232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of two ELISA tests to study the seroprevalence of herpes simplex 1 et 2 infection in a maternity near Paris].
    Benharrosh J; Dauphin H; Porcheret H; Meritet JF; Boulanger MC; Maisonneuve L
    Ann Biol Clin (Paris); 2008; 66(6):665-70. PubMed ID: 19091666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is HSV serology useful for the management of first episode genital herpes?
    Page J; Taylor J; Tideman RL; Seifert C; Marks C; Cunningham A; Mindel A
    Sex Transm Infect; 2003 Aug; 79(4):276-9. PubMed ID: 12902573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.
    Görander S; Mbwana J; Lyamuya E; Lagergård T; Liljeqvist JA
    Clin Vaccine Immunol; 2006 Jun; 13(6):633-9. PubMed ID: 16760320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006.
    Sauerbrei A; Schmitt S; Scheper T; Brandstädt A; Saschenbrecker S; Motz M; Soutschek E; Wutzler P
    Euro Surveill; 2011 Nov; 16(44):. PubMed ID: 22085620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.